EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Age‐Stratified Associations of Sarcopenic Obesity With Mortality in Type 2 Diabetes

Altersstratifizierte Zusammenhänge von sarcopenischer Adipositas mit der Mortalität bei Typ-2-Diabetes

Shinta Yamamoto iD, Yoshitaka Hashimoto iD, Fuyuko Takahashi, Moe Murai, Nozomi Yoshioka, Yuto Saijyo, Chihiro Munekawa, Hanako Nakajima, Noriyuki Kitagawa, Takafumi Osaka, Ryosuke Sakai, Hiroshi Okada und 5 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2026-02 · 17 (1)

DOI: 10.1002/jcsm.70211 ↗

Auf einen Blick

Bei 799 japanischen Personen mit Typ-2-Diabetes war sarcopenische Adipositas mit höherer Mortalität verbunden. Der Zusammenhang war besonders ausgeprägt bei 40- bis 75-Jährigen.

Fragestellung

Ist sarcopenische Adipositas bei Personen mit Typ-2-Diabetes mit Mortalität assoziiert, und unterscheidet sich der Zusammenhang nach Alter?

Methode

Kohortenstudie; Sarcopenie und Adipositas nach Japan Working Group on Sarcopenic Obesity; Cox-Modelle; Subgruppen nach 40-75 vs. >75 Jahren; Sensitivitätsanalyse mit zwei Gruppen.

Ergebnisse

799 Teilnehmende, 41 Todesfälle, medianes Follow-up 46 Monate. Gegenüber weder noch: aHR 2,89 (95 %-KI 1,01–8,30) für sarcopenische Adipositas. Bei 40-75 Jahren aHR 13,1 (2,93–58,4); bei >75 Jahren aHR 1,41 (0,34–8,81).

Schlussfolgerung der Autor:innen

Bei japanischen Personen mit Typ-2-Diabetes war sarcopenische Adipositas signifikant mit erhöhter Mortalität assoziiert. Der Zusammenhang war vor allem bei 40- bis 75-Jährigen ausgeprägt; bei >75-Jährigen war eher Sarcopenie allein assoziiert.

Kernaussagen

  • Sarcopenische Adipositas: aHR 2,89 (95 %-KI 1,01–8,30)
  • Alter 40-75 Jahre: aHR 13,1 (2,93–58,4)
  • >75 Jahre: Sarcopenie allein aHR 3,21 (1,07–8,33)

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 28.01.2026. Verfasst von Shinta Yamamoto und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sarcopenia, Obesity. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenic obesity, the coexistence of sarcopenia and obesity, has been linked to adverse health outcomes due to comorbidity. Evidence on the association between sarcopenic obesity and mortality among individuals with Type 2 diabetes remains limited Methods Sarcopenic obesity was defined using Japan Working Group on Sarcopenic Obesity criteria. Participants were divided into four groups based on the presence of sarcopenia and obesity. Cox proportional hazards models evaluated the mortality risk. Subgroup analyses were performed by age (40–75 vs. >75 years). Sensitivity analysis was performed by dichotomizing participants into sarcopenic obesity and non‐sarcopenic obesity groups.

Results

Of the 799 participants (mean age 68.6 years, 59.3% men), proportions of neither sarcopenia nor obesity, obesity alone, sarcopenia alone and sarcopenic obesity were 56.2%, 34.5%, 6.3% and 3.0%, respectively. During a median follow‐up of 46 months, 41 deaths occurred. Compared with neither of them, the adjusted hazard ratios (aHRs) (95% CI) of mortality in obesity alone, sarcopenia alone and sarcopenic obesity were 0.53 (0.18–1.57) ( p = 0.25), 2.36 (0.99–5.6) ( p = 0.053) and 2.89 (1.01–8.30) ( p = 0.048), respectively. Age‐stratified analyses revealed that sarcopenic obesity markedly increased mortality risk in participants aged 40–75 years (aHR 13.1 [2.93–58.4], p < 0.001), whereas sarcopenia alone (aHR 3.21 [1.07–8.33], p = 0.004), but not sarcopenic obesity (aHR 1.41 [0.34–8.81], p = 0.51), was associated with increased mortality in those aged > 75 years. Compared with non‐sarcopenic obesity, sarcopenic obesity had a significantly higher hazard ratio for mortality (aHR 4.0 [1.44–11.0], p = 0.008). In age‐stratified analysis, this association remained significant in participants aged 40–75 years (aHR 14.1 [3.25–61.5], p < 0.001), but not in those aged > 75 years (aHR 1.55 [0.32–7.46], p = 0.59) (interaction p = 0.03).

Conclusions

In Japanese individuals with Type 2 diabetes, sarcopenic obesity was significantly associated with increased mortality risk. This relationship was particularly pronounced in individuals aged 40–75 years, whereas sarcopenia alone was associated with increased mortality risk rather than sarcopenic obesity in individuals aged > 75.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2SarcopeniaObesityHumansAgedMaleFemaleMiddle AgedAge FactorsAdultRisk Factors

Stichwörter der Autor:innen

Type 2 diabetes mellituscomplicationmortalitysarcopenic obesity

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Department of Diabetes and Endocrinology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Department of Diabetology, Kameoka Municipal Hospital, Kameoka, Japan.
  • Department of Endocrinology and Diabetology, Ayabe City Hospital, Ayabe, Japan.
  • Department of Diabetes and Metabolism, Osaka Railway Hospital, Osaka, Japan.
  • Department of Fundamental Science, Kyoto Institute of Technology, Kyoto, Japan.

ORCID-Profile: Shinta Yamamoto, Yoshitaka Hashimoto

Zitieren

APA

Yamamoto, S., Hashimoto, Y., Takahashi, F., Murai, M., Yoshioka, N., Saijyo, Y., Munekawa, C., Nakajima, H., Kitagawa, N., Osaka, T., Sakai, R., Okada, H., Nakanishi, N., Majima, S., Ushigome, E., Hamaguchi, M., & Fukui, M. (2026). Age‐Stratified Associations of Sarcopenic Obesity With Mortality in Type 2 Diabetes. Journal of Cachexia, Sarcopenia and Muscle, 17(1). https://doi.org/10.1002/jcsm.70211

Vancouver

Yamamoto S, Hashimoto Y, Takahashi F, Murai M, Yoshioka N, Saijyo Y, et al. Age‐Stratified Associations of Sarcopenic Obesity With Mortality in Type 2 Diabetes. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(1). doi:10.1002/jcsm.70211

BibTeX
@article{Yamamoto2026,
  author = {Yamamoto, Shinta and Hashimoto, Yoshitaka and Takahashi, Fuyuko and Murai, Moe and Yoshioka, Nozomi and Saijyo, Yuto and Munekawa, Chihiro and Nakajima, Hanako and Kitagawa, Noriyuki and Osaka, Takafumi and Sakai, Ryosuke and Okada, Hiroshi and Nakanishi, Naoko and Majima, Saori and Ushigome, Emi and Hamaguchi, Masahide and Fukui, Michiaki},
  title = {Age‐Stratified Associations of Sarcopenic Obesity With Mortality in Type 2 Diabetes},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2026},
  volume = {17},
  number = {1},
  doi = {10.1002/jcsm.70211}
}
Kostenlos starten →